Zhou, X., Cella, D., Cameron, D., Amonkar, M.M., Segreti, A., Stein, S., et al. (2009) Lapatinib plus Capecitabine versus Capecitabine Alone for HER2+ (ErbB2) Metastatic Breast Cancer: Quality-of-Life Assessment. Breast Cancer Research and Treatment, 117, 577-589.

卡培他滨单药或联合方案治疗转移性乳腺癌临床疗效观察
Clinical Curative Effect Observation of the Treatment of Metastatic Breast Cancer (MBC) with Capecitabine Medicine or Combination Chemotherapy

李 杰, 李凤虎, 常建英, 李杰慧, 袁 佳, 刘诗苑, 冉 立    科研立项经费支持

临床医学进展Vol.4 No.4, 全文下载: PDF HTML DOI:10.12677/ACM.2014.44016, December 31 2014

细胞周期蛋白D在宫颈癌的研究进展
Research Progress of Cyclin D in Cervical Cancer

梁铭阁, 刘 丽   

临床医学进展Vol.13 No.10, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.13102183, October 9 2023

PIK3CA基因突变与HR阳性且HER2阴性乳腺癌的关系
The Relationship between PIK3CA Mutation and Hormone Receptor Positive and HER2 Negative Breast Cancer

依合里曼·买买提, 梁丽萍, 江志民, 马晓梅   

临床医学进展Vol.13 No.2, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.132384, February 23 2023

CDK4/6抑制剂治疗HR+/HER2?晚期乳腺癌的临床研究进展
Advances in Clinical Research on the CDK4/6 Inhibitors for HR+/HER2? Advanced Breast Cancer

李周娟, 赵久达   

临床医学进展Vol.14 No.3, 全文下载: PDF HTML XML DOI:10.12677/ACM.2024.143724, March 15 2024

P63在HER2低表达乳腺癌中的表达及临床意义
Expression and Clinical Significance of P63 in HER2 Low-Expression Breast Cancer

冯 月, 张立雪, 欧江华   

临床医学进展Vol.13 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.13122621, December 5 2023

曲妥珠单抗、帕妥珠单抗联合多西他赛对晚期三阳性乳腺癌一线治疗的临床疗效
Clinical Efficacy of Trastuzumab, Pertuzumab and Docetaxel as First-Line Treatment for Metastatic Triple-Positive Breast Cancer

曹 宇, 孙 萍   

临床医学进展Vol.12 No.8, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.1281125, August 23 2022